Newborn screening for spinal muscular atrophy with disease-modifying therapies: a cost-effectiveness analysis | Journal of Neurology, Neurosurgery & Psychiatry

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

JNNP 100

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Neurodegeneration

Original research

Newborn screening for spinal muscular atrophy with disease-modifying therapies: a cost-effectiveness analysis

Free

Online download statistics by month:

Online download statistics by month: July 2021 to March 2024

	Abstract	Full	Pdf
Jul 2021	64	52	27
Aug 2021	216	145	104
Sep 2021	84	64	35
Oct 2021	557	47	31
Nov 2021	1316	49	36
Dec 2021	860	81	46
Jan 2022	569	44	27
Feb 2022	527	34	32
Mar 2022	416	54	43
Apr 2022	436	33	27
May 2022	400	44	23
Jun 2022	678	68	55
Jul 2022	564	53	37
Aug 2022	423	42	26
Sep 2022	484	46	28
Oct 2022	361	41	24
Nov 2022	514	37	19
Dec 2022	280	32	22
Jan 2023	286	21	16
Feb 2023	418	42	34
Mar 2023	501	43	24
Apr 2023	653	56	21
May 2023	439	32	15
Jun 2023	250	27	14
Jul 2023	147	102	48
Aug 2023	160	132	52
Sep 2023	163	141	63
Oct 2023	182	145	40
Nov 2023	169	123	60
Dec 2023	151	136	49
Jan 2024	208	149	49
Feb 2024	131	94	51
Mar 2024	164	114	48
Total	12771	2323	1226